
Approval of olaparib offers men first gene-targeted medicine for prostate cancer
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the US…
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the US…
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and…
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…